{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:34:06Z","timestamp":1789011246782,"version":"build-2803163510"},"reference-count":52,"publisher":"Impact Journals, LLC","issue":"27","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,7,4]]},"DOI":"10.18632\/oncotarget.17115","type":"journal-article","created":{"date-parts":[[2017,4,15]],"date-time":"2017-04-15T04:39:25Z","timestamp":1492231165000},"page":"43602-43616","source":"Crossref","is-referenced-by-count":42,"title":["Sphingosine kinase 2 inhibition synergises with bortezomib to target myeloma by enhancing endoplasmic reticulum stress"],"prefix":"10.18632","volume":"8","author":[{"given":"Craig T.","family":"Wallington-Beddoe","sequence":"first","affiliation":[{"name":"Center for Cancer Biology, University of South Australia, Adelaide, Australia"},{"name":"SA Pathology, Adelaide, Australia"},{"name":"School of Medicine, University of Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa K.","family":"Bennett","sequence":"additional","affiliation":[{"name":"Center for Cancer Biology, University of South Australia, Adelaide, Australia"},{"name":"SA Pathology, Adelaide, Australia"},{"name":"School of Medicine, University of Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Vandyke","sequence":"additional","affiliation":[{"name":"SA Pathology, Adelaide, Australia"},{"name":"School of Medicine, University of Adelaide, Australia"},{"name":"South Australian Health and Medical Research Institute, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Davies","sequence":"additional","affiliation":[{"name":"Center for Cancer Biology, University of South Australia, Adelaide, Australia"},{"name":"SA Pathology, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia R.","family":"Zebol","sequence":"additional","affiliation":[{"name":"Center for Cancer Biology, University of South Australia, Adelaide, Australia"},{"name":"SA Pathology, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.B.","family":"Moretti","sequence":"additional","affiliation":[{"name":"Center for Cancer Biology, University of South Australia, Adelaide, Australia"},{"name":"SA Pathology, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa R.","family":"Pitman","sequence":"additional","affiliation":[{"name":"Center for Cancer Biology, University of South Australia, Adelaide, Australia"},{"name":"SA Pathology, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan R.","family":"Hewett","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Adelaide, Australia"},{"name":"South Australian Health and Medical Research Institute, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.W.","family":"Zannettino","sequence":"additional","affiliation":[{"name":"Center for Cancer Biology, University of South Australia, Adelaide, Australia"},{"name":"SA Pathology, Adelaide, Australia"},{"name":"School of Medicine, University of Adelaide, Australia"},{"name":"South Australian Health and Medical Research Institute, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart M.","family":"Pitson","sequence":"additional","affiliation":[{"name":"Center for Cancer Biology, University of South Australia, Adelaide, Australia"},{"name":"SA Pathology, Adelaide, Australia"},{"name":"School of Medicine, University of Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,4,14]]},"reference":[{"key":"1","first-page":"2197","article-title":"Multiple myeloma","volume":"38","author":"Bornhauser","year":"2015","journal-title":"Lancet"},{"key":"2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1586\/17474086.2014.870030","article-title":"An overview of the progress in the treatment of multiple myeloma","volume":"7","author":"Rajkumar","year":"2014","journal-title":"Expert Rev Hematol"},{"key":"3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/2050-7771-1-13","article-title":"The resistance mechanisms of proteasome inhibitor bortezomib","volume":"1","author":"Wang","year":"2013","journal-title":"Biomark Res"},{"key":"4","first-page":"831","article-title":"Endoplasmic reticulum stress and the unfolded protein response: targeting the Achilles heel of multiple myeloma","volume":"1","author":"Samali","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"5","first-page":"1119","article-title":"protein ovERload. Targeting protein degradation to treat myeloma","volume":"9","author":"Dang","year":"2012","journal-title":"Haematologica"},{"key":"6","first-page":"1","article-title":"The role of endoplasmic reticulum stress in maintaining and targeting multiple myeloma: a double-edged sword of adaptation and apoptosis","volume":"4","author":"Liu","year":"2013","journal-title":"Front Genet"},{"key":"7","first-page":"4907","article-title":"Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells","volume":"10","author":"Boise","year":"2006","journal-title":"Blood"},{"key":"8","first-page":"5317","article-title":"Roles, regulation and inhibitors of sphingosine kinase 2","volume":"28","author":"Pitson","year":"2013","journal-title":"FEBS J"},{"key":"9","first-page":"2803","article-title":"Sphingosine kinase 2 promotes acute lymphoblastic leukemia by enhancing MYC expression","volume":"7","author":"Bendall","year":"2014","journal-title":"Cancer Res"},{"key":"10","first-page":"1254","article-title":"Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate","volume":"32","author":"Spiegel","year":"2009","journal-title":"Science"},{"key":"11","first-page":"1915","article-title":"Inhibition of sphingosine kinase 2 downregulates the expression of c-Myc and Mcl-1 and induces apoptosis in multiple myeloma","volume":"12","author":"Smith","year":"2014","journal-title":"Blood"},{"key":"12","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S1097-2765(00)80283-X","article-title":"ASK1 is essential for JNK\/SAPK activation by TRAF2","volume":"2","author":"Ichijo","year":"1998","journal-title":"Mol Cell"},{"key":"13","first-page":"664","article-title":"Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1","volume":"28","author":"Ron","year":"2000","journal-title":"Science"},{"key":"14","first-page":"1149","article-title":"Modeling risk stratification in human cancer","volume":"2","author":"Klein","year":"2013","journal-title":"Bioinformatics"},{"key":"15","doi-asserted-by":"publisher","first-page":"16663","DOI":"10.18632\/oncotarget.7693","article-title":"Proteasomal degradation of sphingosine kinase 1 and inhibition of dihydroceramide desaturase by the sphingosine kinase inhibitors, SKi or ABC294640, induces growth arrest in androgen-independent LNCaP-AI prostate cancer cells","volume":"7","author":"Pyne","year":"2016","journal-title":"Oncotarget"},{"key":"16","first-page":"2744","article-title":"The Sphingosine Kinase 2 Inhibitor ABC294640 Reduces the Growth of Prostate Cancer Cells and Results in Accumulation of Dihydroceramidesand","volume":"1","author":"Voelkel-Johnson","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"17","doi-asserted-by":"crossref","first-page":"e56471","DOI":"10.1371\/journal.pone.0056471","article-title":"Biological characterization of 3-(2-amino-ethyl)-5- [3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione (K145) as a selective sphingosine kinase-2 inhibitor and anticancer agent","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"18","first-page":"26","article-title":"The control of the balance between ceramide and sphingosine-1-phosphate by sphingosine kinase: Oxidative stress and the seesaw of cell survival and death","volume":"16","author":"Williams","year":"2012","journal-title":"Comp Biochem Physiol B Biochem Mol Biol"},{"key":"19","first-page":"487","volume-title":"Enzymes and metabolic inhibitors","author":"Quastel","year":"1963"},{"key":"20","first-page":"53","article-title":"XBP1 controls diverse cell type- and condition-specific transcriptional regulatory networks","volume":"2","author":"Dynlacht","year":"2007","journal-title":"Mol Cell"},{"key":"21","first-page":"92","article-title":"IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA","volume":"41","author":"Ron","year":"2002","journal-title":"Nature"},{"key":"22","first-page":"64","article-title":"Response of myeloma to the proteasome inhibitor bortezomib is correlated with the unfolded protein response regulator XBP-1","volume":"9","author":"Allen","year":"2012","journal-title":"Haematologica"},{"key":"23","first-page":"67","article-title":"Lipid-dependent regulation of the unfolded protein response","volume":"3","author":"Ron","year":"2015","journal-title":"Curr Opin Cell Biol"},{"key":"24","first-page":"273","article-title":"Disruption of ceramide synthesis by CerS2 down-regulation leads to autophagy and the unfolded protein response","volume":"42","author":"Obeid","year":"2009","journal-title":"Biochem J"},{"key":"25","first-page":"489","article-title":"The nonlysosomal beta-glucosidase GBA2 promotes endoplasmic reticulum stress and impairs tumorigenicity of human melanoma cells","volume":"2","author":"Andrieu-Abadie","year":"2013","journal-title":"FASEB J"},{"key":"26","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s12307-011-0072-9","article-title":"Angiogenesis and multiple myeloma","volume":"4","author":"Bonomini","year":"2011","journal-title":"Cancer Microenviron"},{"key":"27","first-page":"830307","article-title":"Methods for monitoring endoplasmic reticulum stress and the unfolded protein response","volume":"201","author":"Gupta","year":"2010","journal-title":"Int J Cell Biol"},{"key":"28","first-page":"572","article-title":"SAMSN1 is a tumor suppressor gene in multiple myeloma","volume":"1","author":"Zannettino","year":"2014","journal-title":"Neoplasia"},{"key":"29","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1158\/1535-7163.MCT-07-0121","article-title":"Detection of myeloma in skeleton of mice by whole-body optical fluorescence imaging","volume":"6","author":"Mundy","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"30","first-page":"814","article-title":"Mouse models as a translational platform for the development of new therapeutic agents in multiple myeloma","volume":"1","author":"Tagliaferri","year":"2012","journal-title":"Curr Cancer Drug Targets"},{"key":"31","first-page":"24","article-title":"Tetraspanin 7 (TSPAN7) expression is upregulated in multiple myeloma patients and inhibits myeloma tumour development","volume":"33","author":"Vandyke","year":"2015","journal-title":"Exp Cell Res"},{"key":"32","first-page":"343","article-title":"The effect of the dual PI3K and mTOR inhibitor BEZ235 on tumour growth and osteolytic bone disease in multiple myeloma","volume":"9","author":"Martin","year":"2015","journal-title":"Eur J Haematol"},{"key":"33","first-page":"380","article-title":"The effect of the PI3K inhibitor BKM120 on tumour growth and osteolytic bone disease in multiple myeloma","volume":"3","author":"Zannettino","year":"2015","journal-title":"Leuk Res"},{"key":"34","first-page":"387","article-title":"Therapeutic targeting of N-cadherin is an effective treatment for multiple myeloma","volume":"17","author":"Vandyke","year":"2015","journal-title":"Br J Haematol"},{"key":"35","first-page":"268","article-title":"Myeloma cells exhibit an increase in proteasome activity and an enhanced response to proteasome inhibition in the bone marrow microenvironment in vivo","volume":"8","author":"Mundy","year":"2009","journal-title":"Am J Hematol"},{"key":"36","first-page":"815","article-title":"The Proteasome Inhibitor Bortezomib Maintains Osteocyte Viability in Multiple Myeloma Patients by Reducing Both Apoptosis and Autophagy: A New Function for Proteasome Inhibitors","volume":"3","author":"Craviotto","year":"2016","journal-title":"J Bone Miner Res"},{"key":"37","first-page":"233","article-title":"Bortezomib increases osteoblast activity in myeloma patients irrespective of response to treatment","volume":"7","author":"Sezer","year":"2006","journal-title":"Eur J Haematol"},{"key":"38","first-page":"2025","article-title":"Bortezomib inhibits human osteoclastogenesis","volume":"2","author":"Sezer","year":"2007","journal-title":"Leukemia"},{"key":"39","first-page":"799","article-title":"Regulation of sphingosine kinase in hematological malignancies and other cancers","volume":"1","author":"Bonder","year":"2011","journal-title":"Anticancer Agents Med Chem"},{"key":"40","first-page":"623","article-title":"Oncogenic properties of sphingosine kinases in haematological malignancies","volume":"16","author":"Bendall","year":"2013","journal-title":"Br J Haematol"},{"key":"41","first-page":"37118","article-title":"SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism","volume":"28","author":"Spiegel","year":"2005","journal-title":"J Biol Chem"},{"key":"42","first-page":"5055","article-title":"Sphingosine-1-phosphate phosphohydrolase regulates endoplasmic reticulum-to-golgi trafficking of ceramide","volume":"2","author":"Spiegel","year":"2006","journal-title":"Mol Cell Biol"},{"key":"43","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1743-7075-9-71","article-title":"Mechanisms involved in cellular ceramide homeostasis","volume":"9","author":"Jiang","year":"2012","journal-title":"Nutr Metab (Lond)"},{"key":"44","first-page":"135","article-title":"Activation of sphingosine kinase 2 by endoplasmic reticulum stress ameliorates hepatic steatosis and insulin resistance in mice","volume":"6","author":"Park","year":"2015","journal-title":"Hepatology"},{"key":"45","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.celrep.2014.08.057","article-title":"Central ceramide-induced hypothalamic lipotoxicity and ER stress regulate energy balance","volume":"9","author":"Dieguez","year":"2014","journal-title":"Cell Rep"},{"key":"46","first-page":"4628","article-title":"Membrane lipid saturation activates endoplasmic reticulum unfolded protein response transducers through their transmembrane domains","volume":"11","author":"Ron","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"47","first-page":"24","article-title":"How IRE1 reacts to ER stress","volume":"13","author":"Hubbard","year":"2008","journal-title":"Cell"},{"key":"48","first-page":"1347","article-title":"Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP Kinase","volume":"27","author":"Ron","year":"1996","journal-title":"Science"},{"key":"49","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3324\/haematol.2009.012674","article-title":"Peripheral neuropathy and new treatments for multiple myeloma: background and practical recommendations","volume":"9","author":"Mohty","year":"2010","journal-title":"Haematologica"},{"key":"50","doi-asserted-by":"crossref","unstructured":"Moruno-Manchon, Uzor, Blasco, Mannuru, Putluri, Furr-Stimming, Tsvetkov. Inhibiting sphingosine kinase 2 mitigates mutant huntingtin-induced neurodegeneration in neuron models of Huntington disease. Hum Mol Genet. 2017.","DOI":"10.1093\/hmg\/ddx046"},{"key":"51","first-page":"129","article-title":"Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2","volume":"33","author":"Smith","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"52","doi-asserted-by":"publisher","first-page":"7065","DOI":"10.18632\/oncotarget.3178","article-title":"A selective ATP-competitive sphingosine kinase inhibitor demonstrates anti-cancer properties","volume":"6","author":"Pitson","year":"2015","journal-title":"Oncotarget"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.17115","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T17:58:14Z","timestamp":1597687094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.17115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,14]]},"references-count":52,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2017,7,4]]}},"alternative-id":["17115","28467788"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.17115","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,14]]}}}